# | Title | Journal | Year | Citations |
---|
1 | Mutations of the VHL tumour suppressor gene in renal carcinoma | Nature Genetics | 1994 | 1,612 |
2 | Epidemiology and Risk Factors of Urothelial Bladder Cancer | European Urology | 2013 | 1,572 |
3 | Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer | Nature Genetics | 2012 | 1,300 |
4 | Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision | Human Reproduction | 1999 | 739 |
5 | The standardisation of terminology in nocturia: Report from the standardisation sub-committee of the International Continence Society | Neurourology and Urodynamics | 2002 | 578 |
6 | The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer | Nature Communications | 2014 | 522 |
7 | Distribution of metastatic sites in renal cell carcinoma: a population-based analysis | Annals of Oncology | 2012 | 478 |
8 | Tolterodine and Tamsulosin for Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder | JAMA - Journal of the American Medical Association | 2006 | 472 |
9 | Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer | Journal of Clinical Oncology | 2005 | 468 |
10 | Generation of functional multipotent adult stem cells from GPR125+ germline progenitors | Nature | 2007 | 430 |
11 | An Analysis of the Natural History of Peyronie’s Disease | Journal of Urology | 2006 | 348 |
12 | Do sperm DNA integrity tests predict pregnancy with in vitro fertilization? | Fertility and Sterility | 2008 | 346 |
13 | Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody | Lab on A Chip | 2010 | 346 |
14 | Perioperative Outcomes of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy: Results From the Nationwide Inpatient Sample | European Urology | 2012 | 345 |
15 | Structural and functional changes to the testis after conventional versus microdissection testicular sperm extraction | Urology | 2005 | 307 |
16 | AROMATASE INHIBITORS FOR MALE INFERTILITY | Journal of Urology | 2002 | 305 |
17 | Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer | Neoplasia | 2010 | 305 |
18 | Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy | ChemMedChem | 2008 | 297 |
19 | Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins | Journal of Urology | 2013 | 291 |
20 | Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer | Journal of Clinical Oncology | 2004 | 290 |
21 | Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes | BJU International | 2014 | 274 |
22 | Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis | European Urology | 2011 | 259 |
23 | A Comparison of Postoperative Complications in Open versus Robotic Cystectomy | European Urology | 2010 | 258 |
24 | INCREASED INCIDENCE OF TESTICULAR CANCER IN MEN PRESENTING WITH INFERTILITY AND ABNORMAL SEMEN ANALYSIS | Journal of Urology | 2005 | 251 |
25 | Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4 | Nature Medicine | 2017 | 240 |
26 | Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen | Journal of Urology | 2003 | 238 |
27 | Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer | European Urology | 2015 | 235 |
28 | Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability | American Journal of Medicine | 2006 | 228 |
29 | Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis | Cancer Epidemiology | 2013 | 222 |
30 | A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An Update | European Urology | 2016 | 218 |
31 | The influence of prostate size on cancer detection | Urology | 1995 | 217 |
32 | Comparison of microdissection testicular sperm extraction, conventional testicular sperm extraction, and testicular sperm aspiration for nonobstructive azoospermia: a systematic review and meta-analysis | Fertility and Sterility | 2015 | 217 |
33 | Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy | BJU International | 2008 | 215 |
34 | Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers | Human Pathology | 2009 | 209 |
35 | Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors | Journal of Clinical Oncology | 2007 | 208 |
36 | Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction | European Urology | 2007 | 207 |
37 | Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer | Molecular Carcinogenesis | 2011 | 206 |
38 | The Mutational Landscape of Prostate Cancer | European Urology | 2013 | 203 |
39 | The Use of an Erectogenic Pharmacotherapy Regimen Following Radical Prostatectomy Improves Recovery of Spontaneous Erectile Function | Journal of Sexual Medicine | 2005 | 201 |
40 | Renal artery embolization: clinical indications and experience from over 100 cases | BJU International | 2007 | 201 |
41 | Importance of and Satisfaction with Sex Among Men and Women Worldwide: Results of the Global Better Sex Survey | Journal of Sexual Medicine | 2008 | 195 |
42 | Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder | British Journal of Cancer | 2013 | 192 |
43 | Standards for Surgical Complication Reporting in Urologic Oncology: Time for a Change | Urology | 2007 | 191 |
44 | A Novel Cytoplasmic Tail MXXXL Motif Mediates the Internalization of Prostate-specific Membrane Antigen | Molecular Biology of the Cell | 2003 | 188 |
45 | Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma | European Urology | 2012 | 188 |
46 | Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the Bladder | Clinical Cancer Research | 2005 | 184 |
47 | The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society | BJU International | 2002 | 182 |
48 | Pelvic Lymph Node Dissection During Robot-assisted Radical Prostatectomy: Efficacy, Limitations, and Complications—A Systematic Review of the Literature | European Urology | 2014 | 180 |
49 | Cryopreservation of Sperm: Indications, Methods and Results | Journal of Urology | 2003 | 175 |
50 | Anatomical grades of nerve sparing: a risk‐stratified approach to neural‐hammock sparing during robot‐assisted radical prostatectomy (RARP) | BJU International | 2011 | 173 |